Lexeo Therapeutics (LXEO) Free Cash Flow: 2022-2023
Historic Free Cash Flow for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to -$14.0 million.
- Lexeo Therapeutics' Free Cash Flow rose 15.78% to -$14.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$59.6 million, marking a year-over-year change of. This contributed to the annual value of -$81.6 million for FY2024, which is 36.94% down from last year.
- Per Lexeo Therapeutics' latest filing, its Free Cash Flow stood at -$14.0 million for Q4 2023, which was down 0.39% from -$14.0 million recorded in Q3 2023.
- Lexeo Therapeutics' Free Cash Flow's 5-year high stood at -$13.2 million during Q2 2023, with a 5-year trough of -$18.4 million in Q1 2023.
- For the 2-year period, Lexeo Therapeutics' Free Cash Flow averaged around -$15.3 million, with its median value being -$14.0 million (2023).
- Data for Lexeo Therapeutics' Free Cash Flow shows a peak YoY grew of 15.78% (in 2023) over the last 5 years.
- Lexeo Therapeutics' Free Cash Flow (Quarterly) stood at -$16.7 million in 2022, then climbed by 15.78% to -$14.0 million in 2023.
- Its Free Cash Flow stands at -$14.0 million for Q4 2023, versus -$14.0 million for Q3 2023 and -$13.2 million for Q2 2023.